Now that we've projected contracts for the top 50 free agents in this winter's class, let's look at which players could provide the most -- and least -- bang for their expected buck.
In past years, I've done pretty well -- investing in Sonny Gray, Shane Bieber and Shota Imanaga as free agents while avoiding the end of Justin Turner's career and megadeals for players whom teams initially didn't sign to long-term contracts that offseason, like Blake Snell, Pete Alonso, and Cody Bellinger, before they all eventually got those deals.
Last year, my biggest player to invest in was a hit (Michael King), and my five players to avoid combined for -0.3 WAR at over $62 million in salary and over $40 million in future commitments. Now, I'm back again to try to hit the bull's-eye a few more times.
The projected contracts in my rankings provide important context for this exercise, as my choices are based on return on investment -- how I expect the players to perform over the length of their deals at their projected prices.
The rules for this edition are the same I set out for myself last winter: Each group of three players must have one player projected to land more than $50 million, one projected for a one-year deal and at least one pitcher and one position player.
Here are my three free agents to invest in and three to avoid for the 2026-27 MLB offseason.
Free Agents to invest in
Seiya Suzuki, RF, age: 32
Projected contract: 4 years, $90 million (22.5 AAV)
Suzuki has been one of the most consistent outfielders in baseball over the past four seasons. Among regular outfielders, he's fifth (behind Aaron Judge, Juan Soto, Ronald Acuna Jr., and Kyle Tucker) in the all-encompassing batting stat wRC+ and 12th in WAR in that span. Suzuki's WAR number drags a bit because his defense in right field had been league average to slightly below, but it ticked up dramatically to plus in 2026. Normally, those results don't hold to the next season for players in their 30s, but it at least sets a higher baseline for Suzuki's decline.
I'm not sure what the high-end market will be for the hitters vying for the second-biggest contract of the winter (behind Tarik Skubal), but Suzuki has a strong case and could get the fifth year and/or crack $100 million. Given his age and position, I think he might come up a bit short, but Suzuki comes with a high floor due to several routes to create value.
When it comes to big-money free agents to invest in, higher-floor hitters with a strong track record of performance and durability are the safest bet, and safety is the name of the game, as obvious values don't exist at this price point. He's very likely to continue playing at a 2.5- to 3.5-win level for the next two or three years, so the risk is just the last year or two of the contract.
Jazz Chisholm Jr., 2B, age: 28
Projected contract: two years, $46 million (23 AAV)
It was a slam dunk that he'd be one of my three "invest" players after I read the market and projected Chisholm to get this contract. Among regular infielders, he's 11th in WAR (11.8, averaging just under 4.0 per season) over the past three seasons, just behind some of the best players in baseball: Bobby Witt Jr., Elly De La Cruz, Gunnar Henderson, Francisco Lindor, Jose Ramirez, Geraldo Perdomo, Ketel Marte, Alex Bregman, Brice Turang, and Jeremy Pena. On top of that, Chisholm is still just 28 and the Yankees didn't extend a qualifying offer to him.
But here are the reasons I think he settles for a short-term deal: His batting average has trended from .256 to .242 to .231 last season, and his strikeout rate has jumped 5% and his 2026 expected wOBA (an all-encompassing hitting statistic with ball-in-play "luck" stripped out) fell to career lows. In addition, his actual wOBA was well better than his expected, so he's trending down in most major categories and also was "lucky" last season. His strong WAR (3.5) is propped up by defensive metrics that some believe don't reflect reality for infielders due to positioning, so you could argue that a DRS-driven WAR (likely in the low-to-mid 2s) is more indicative of his ability.
He is a good bet to get a contract at or near the qualifying offer (one-year, $23.15 million contract), so it would appear the Yankees didn't offer that because they didn't want to risk him seeing a down market and taking the offer to return to the Bronx for 2027. It's hard to quantify exactly why the Yankees feel that way -- I'm sure Yankees fans don't have trouble imagining the reasons -- but Chisholm put up 3.5 WAR this season, eighth among second basemen, in a notably bad season for him. Even if he doesn't improve, he isn't in physical decline and offers lots of baserunning and positional value along with routinely beating his expected hitting numbers due in large part to his speed. So, on a one- or two-year deal for something like the qualifying-offer rate, Chisholm's contract is unlikely to be a heavily negative ROI and clearly has the ability to post a 5-win season if he can make some adjustments; this is something financial professionals call asymmetric risk.
Bryan Abreu, RHP, age: 29
Projected contract: 1 year, $10.5 million
There are a lot of options for this last spot every year, and they are often candidates for pillow contracts, which are one-year deals that can help free agents reestablish their value next offseason. That describes Abreu to a T, along with some other late cuts for this list: Zac Gallen, Daulton Varsho, Trent Grisham and Nick Pivetta (mostly health-based in his case). Two others who got strong consideration were Adrian Morejon, Kris Bubic (not quite enough highly positive ROI potential, but I think both will be worth their contracts) and Hiromi Itoh (limited upside, but also has asymmetric risk). I was considering Evan Phillips before he landed a surprising three-year deal from the Braves.
In Abreu's case, he looked like a potential $50-plus million free agent reliever at this point last year, then had a disastrous 2026 season, when his fastball velocity lost 1.5 mph, slider broke less, walks were way up, strikeouts were down, and he had an almost double home run rate. Because he's still in his 20s and he still struggled with some mechanical and confidence issues this season, there's a clear case that a new coach, a change of scenery and rebuilding his mechanics could help him become his former self as soon as next season.
There's a lot of upside to bringing Abreu back to his former self and not that much downside; I could also see him landing a two-year deal if there are several teams confident that they can fix what ails him.

Free agents to avoid
Randy Arozarena, LF, age: 31
Projected contract: four years, $90 million (22.5 AAV)
Arozarena set a benchmark of 2.5-or-so wins per season from 2022 to 2025, putting up 10.7 WAR over those four years, when it was never below 2.0 or above 3.1. This is relevant because, at age 31 in a walk year, Arozarena put up 5.5 WAR while having top-10 ball-in-play luck in the league, and being below average by any defensive metric in left field.
This means Arozarena is having average luck and also aging similarly to most players, and he projects in 2027 to post 2.0 to 2.5 WAR, without adjusting for more defensive or baserunning decline. If the per-year price will be over $20 million, the team signing him will basically be breaking even in Year 1 of a likely long-term deal, leaving very little room for this to be a good value and tons of room for a disastrous outcome.
Anthony Santander had two straight 2.5ish-WAR seasons, then 3.2 WAR in a walk year at age 30, then -0.9 WAR in the first year of his new deal, and didn't play in the second year. Chris Davis went from a 0.9-WAR season to a 5.4-WAR season in a walk year at age 29, then fell off in historic fashion. Josh Hamilton posted a 4.8-WAR season at age 31 in a walk year, then posted 2.8 WAR for the rest of his career. Teoscar Hernandez posted a 3.4-WAR season at age 31 in a walk year, then put up 1.8 WAR over the next two seasons combined. But that doesn't mean Arozarena will follow these comps, but there's a pattern with spikes in walk years for corner outfielders and/or outfielders in their 30s. There's always demand for middle-of-the-order production and power hitters, so there are always teams willing to take a chance.
Ian Happ, LF, age: 32
Projected contract: three years, $48 million (16 AAV)
Happ is a cleaner 'corner outfielder in decline' case than Arozarena, with his WAR dropping (3.7, then 2.8, then 2.6) similar to his wRC+ (121, 116, 107) and similar to his expected wOBA, with a slight headfake into a down year in 2026 (.347, .354, .313). Similar to teammate Suzuki in the above section, Happ also had a defensive improvement in his 30s, but he has been in positive territory for a few years, helped by his arm as well as his range.
That helps Happ's case for a more gentle decline defensively, but he'll likely get a multiyear deal, so he will decline defensively and physically during this deal, and if his hitting doesn't rebound, he might be in a platoon role (he has pretty big righty/lefty splits) where his defensive ability isn't as important in lesser playing time. I feel pretty good about Happ being a starter-level contributor next season, but not far beyond that, so the downside in the projected contract (or even a two-year deal) is paying two times to three times the player's value in the second and/or third year of the deal after not delivering much surplus value in that first year.
Chris Bassitt, RHP, age: 37
Projected contract: one year, $10 million
Bassit gets the edge over some other risky bets, such as Tarik Skubal (the eight-to-10-year deal is scaring off several teams, but he'll be a star for most or all of the front end of the deal), Ryan Jeffers (catchers are inherently risky, and there isn't a ton of upside), and Ty France (he might have been lightning in a bottle in 2026, but he's still decent, especially for a one-year deal for 2027), but each of them project for a solid enough ROI that Bassitt has real potential to be released in 2027 if he can't turn the tides.
Bassitt signed last winter for one year and $18.5 million and was terrible in the first half before missing two months because of a back issue. When he came back, his velocity and results were a bit better, but still below average. He'll be 38 years old in February, and the optimistic pitch for 2027 is that he'll be a version of his post-IL-return self, with a mid-4.00 ERA in a bulk-inning role, but that gives almost no path to success from an ROI standpoint. The signing team would be hoping it all clicks for a 1.5-WAR season in an ideal scenario in which he'd then get moved to long relief or off the roster in the playoffs. But there is also a path to continued decline/injuries and scenarios where a one-year deal could be seen as a bad investment.
